United States · Bill · S
S. 3116 (116th)
Ending the Diagnostic Odyssey Act of 2019
Introduced
19 December 2019
Last action
—
Status
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211)
Sponsors
—
Subjects
Discovery layer
Source updated
5 December 2025
Summary
Ending the Diagnostic Odyssey Act of 2019 This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 19 December 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 19 December 2019
Introduced in Senate
summary · EN · 19 December 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/3116
- Open data entity: https://api.congress.gov/v3/bill/116/s/3116